Jupiter Life Line Hospitals Limited (NSE:JLHL)
India
· Delayed Price · Currency is INR 1,442.90
-24.70 (-1.68%)
May 2, 2025, 9:30 AM IST
NSE:JLHL Revenue
Jupiter Life Line Hospitals had revenue of 3.21B INR in the quarter ending December 31, 2024, with 17.62% growth. This brings the company's revenue in the last twelve months to 12.22B, up 18.43% year-over-year. In the fiscal year ending March 31, 2024, Jupiter Life Line Hospitals had annual revenue of 10.71B with 19.90% growth.
Revenue (ttm)
12.22B
Revenue Growth
+18.43%
P/S Ratio
7.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
96.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 10.71B | 1.78B | 19.90% |
| Mar 31, 2023 | 8.93B | 1.56B | 21.13% |
| Mar 31, 2022 | 7.37B | 2.47B | 50.35% |
| Mar 31, 2021 | 4.90B | 273.24M | 5.90% |
| Mar 31, 2020 | 4.63B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |